Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Anthony Sauve
Weill Medical Coll of Cornell Univ, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Chromadex, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The work involves studies focused upon the effects of nicotinamide riboside a novel form of VItamin B3, which can increase sirtuin activity, decrease reactive oxygen and increase physiologic NAD concentrations. These studies involve patent for nicotinamide riboside synthesis and uses issued to Cornell Center for Technology Enterprise and Commercialization (CCTEC) and Dr. Anthony Sauve.
Nicotinamide Riboside and NAD+: Modulation of Sirtuins and Reactive Oxygen
The grant application is designed to optimize and apply a novel activity-based probe that can penetrate cells and label sirtuins, a class of enzymes implicated in mediating the health beneficial effects of low calorie diets. The probe can be visualized and it exhibits sensitivity to cell perturbations such as increased NAD+ concentrations or changes in cell signaling. The development and application of this tool is expected to provide a major leap forward in technology to study sirtuins and is expected to help address key questions of relevance to the sirtuin field.
Filed on June 04, 2013.
Tell us what you know about Anthony Sauve's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Anthony Sauve filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Anthony Sauve | Weill Medical Coll of Cornell Univ | Conflict of Interest | Chromadex, Inc. | $5,000 - $9,999 |
| Anthony Sauve | Weill Medical Coll of Cornell Univ | Conflict of Interest | Chromadex, Inc. | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.